Introduction: Drugs which primarily prolong cardiac refractoriness decrease defibrillation voltage and energy requirements in animals and man. The effect of such drugs on ventricular fibrillation itself is not well understood. We hypothesized that tedisamil, an investigational antiarrhythmic drug which blocks I and I repolarizing potassium channels, would increase organization of epicardial to K electrograms during ventricular fibrillation while it lowered defibrillation energy requirements. Methods: We measured magnitude-squared Ž . Ž . coherence, a measure of spatial organization, and ventricular fibrillation VF cycle length, ventricular effective refractory period VERP , Ž . Ž . and monophasic action potential duration APD as well as defibrillation energy threshold E at baseline and after 150 mgrkg of 90 50 Ž . Ž . tedisamil n s 13 or saline control n s 6 in an open chest dog model. Results: After tedisamil, mean magnitude-squared coherence Ž . increased by 132 " 133%, from 0.15 " 0.08 to 0.31 " 0.16 P -0.001 ; VF cycle length increased from 121 " 24 to 190 " 63 ms Ž . P -0.001 and became more regular, with the coefficient of variation between adjacent VF intervals decreasing from 14.1 " 6.9 to Ž . Ž . 3.9 " 2.2% P -0.001 . Mean E decreased from 8.9 " 3.8 to 6.1 " 2.7 joules P -0.001 ; VERP increased from 158 " 30 to 50 Ž . Ž . 201 " 31 ms P -0.001 , and APD increased from 177 " 25 to 244 " 45 ms P -0.001 after tedisamil. No electrophysiologic 90 parameter was changed after saline infusion. Conclusions: Tedisamil increases both spatial coherence and temporal regularity of ventricular fibrillation. These effects on 'order' during VF may be in part responsible for the observed reduction in defibrillation energy requirements.
Ž
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Introduction
The widespread use of implantable cardioverter defibrillators has generated interest in the effect of antiarrhythmic drugs on the voltage and energy requirements for cardiac defibrillation. Drugs which primarily prolong ventricular refractoriness are consistently associated with a decrease in defibrillation energy requirements in a variety of species, including man. Drugs thus far studied have largely included relatively selective blockers of the rapidly activat-Ž . ing component of the I repolarizing current I such as K K r w x w x w x w x sotalol 1 , dofetilide 2 , E-4031 3 , NAPA 4 , but have also included less selective potassium channel blockers w x such as clofilium 5 . The relatively selective I blocker, K1 barium, has also been reported to decrease defibrillation ) Corresponding author. Tel. q1 416 864-5104; Fax q1 416 864-5336. w x voltage and energy requirements 6 . It is not clear from these studies whether lowering of defibrillation energy is the result of the block of one or more particular potassium channels, or a generalized response to action potential w x prolongation 4,6 .
Ž . The mechanism s of drug-induced decreases in defibrillation voltage and energy requirements are not clear. High-voltage shocks appear to defibrillate, at least in part, by synchronizing the repolarization of cardiac elements which are repolarizing asynchronously during ventricular Ž . w x fibrillation VF 7 , and by prolonging or 'extending' the refractory period of cardiac cells as a consequence of the w x shock 8 . As a result of these processes, fibrillatory wavew x fronts may be extinguished 9 or prevented from being w x reinitiated 10 . Antiarrhythmic drugs with class III proper-ties may enhance these processes, allowing shocks to be more effective at synchronizing repolarization or further extending refractory periods. However, refractory period w x extension is not enhanced by dofetilide, an I blocker 2 .
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Based on preliminary observations following barium w x w x 11 and sotalol 12 administration, we hypothesized that drugs with class III properties may alter the nature of the fibrillatory process itself, increasing the temporal and spatial organization of the rhythm which precedes the shock. If the sequences of depolarization and repolarization are more spatially coherent, one may expect that the ability of shocks to synchronize repolarization would be enhanced.
The detailed effects of antiarrhythmic drugs on organization in ventricular fibrillation have not been previously studied. We used tedisamil, an investigational class III w x antiarrhythmic agent 13 which blocks the I and a to Ž . slowly activating component of I presumably I potask K s w x sium channels 14,15 , and which would be expected to potently block K q channels during ventricular fibrillation, when cells are almost constantly depolarized and frew x quently activated 16 . Tedisamil was shown to prevent sustained VF and to slow VF cycle length in a rat model of w x ischemic and reperfusion-associated VF 17,18 .
We used the mean magnitude-squared coherence funcw x tion 19 to assess organization; this parameter has been advocated to separate ventricular fibrillation from more w x organized ventricular tachycardia 20,21 . We thus studied the effect of tedisamil on defibrillation voltage and energy requirements, indices of cardiac repolarization, and spatial coherence during ventricular fibrillation.
Methods

Surgical procedure
The experiment was approved by the Animal Care Committee of the Toronto Hospital and conforms to the guiding principles of the Canadian Council on Animal Care.
Ž . Nineteen mongrel dogs 20.0 " 2.9 kg, range 15-24 kg were anesthetized with 30 mgrkg of pentobarbital, followed by a constant intravenous infusion at 2-3 mgrkgrh. They were ventilated with 50% O rN mixture through a 2 2 Ž cuffed endotracheal tube by a Harvard respirator Harvard . Apparatus, South Natick, MA , with a tidal volume and rate set to maintain the pCO , pO , and pH in the physio- 2 2 logical range. A femoral arterial cannula was used for Ž continuous blood pressure measurement by a Statham . transducer P23Id, Bionetics Inc., Toronto, Ont. and blood gas sampling. A femoral vein was catheterized for subsequent drug infusion. Blood pressure and lead II of the electrocardiogram and a bipolar electrogram from epicardial screw-in electrodes were continuously displayed on a Ž . paper recorder Instromedix, Inc., Hillsboro, OR at speeds between 25 and 100 mmrs.
Through a left lateral thoracotomy, two circular tita-2 Ž nium mesh defibrillation electrodes, 7.6 cm each Ventri-. tex Inc., Sunnyvale, CA were implanted on the upper lateral right ventricular and the lower lateral left ventricular epicardium. Four platinum-iridium screw-in electrodes Ž . Daig Corp., Minnetonka, MN were inserted for the in-Ž . duction of ventricular fibrillation 1st bipolar pair and the Ž measurement of ventricular refractory periods 2nd bipolar . pair . Two Ag-AgCl button electrodes, with 3 electrodes per button, interelectrode distance s 3 mm on each Ž button and the two buttons 3 cm apart a distance chosen after pilot experiments showed low coherence in control . experiments , were sewn on to the left ventricular epicardium for monitoring epicardial electrograms. Unipolar electrograms using a reference electrode in the inferior vena cava in the abdomen were recorded. A bullseye bipolar electrode with a central button surrounded by a concentric recording ring 0.3 mm distant was sewn to the left ventricular epicardium to record local electrograms for w x calculation of ventricular fibrillation cycle length 16 . Signals were filtered at DC-500 Hz. Monophasic action Ž potentials using a contact electrode EP Technologies Inc., . Sunnyvale, CA were recorded in 14 dogs from the right ventricular endocardium and amplified and filtered at DC 5000 Hz. All electrograms were stored to digital tape Ž . Teac, Corp., Montebello, CA for subsequent off-line analysis, at a sampling frequency of 2 kHz.
Defibrillation energy and Õoltage requirement testing
Fibrillation-defibrillation sequences were performed as Ž . follows: ventricular fibrillation VF was induced with the application of 2 s of 15 V of fully rectified 60 Hz current through a pair of epicardial electrodes and its presence was verified by the electrocardiogram recording and the absence of blood pressure. After 15 s of VF, shocks of varying voltage were delivered as outlined below. If a shock was unsuccessful, a 'rescue shock' of higher voltage was applied immediately. No fibrillation-defibrillation sequence lasted more than 45 s.
Defibrillation shocks were applied by the use of a Ž battery-operated external cardioverter defibrillator HVS-. 02, Ventritex Inc., Sunnyvale, CA which delivers monophasic truncated trapezoidal discharges of preset voltage and duration. Defibrillation thresholds were measured using the up-down technique as follows: After an initial 500 V shock, initial shock strength was decreased by 50 V after each success and increased by 50 V after each failure to defibrillate. A 'threshold' was defined as the voltage of the lowest successful shock for a pair of shocks 50 V apart with the higher voltage being successful and the lower voltage unsuccessful in defibrillation. Only test shocks Ž . and not 'rescue' shocks were used in this analysis.
Three successive defibrillation thresholds were aver-Ž aged to estimate the V voltage level associated with a
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. w x 50% probability of defibrillation 22 . Delivered energy in 
Ž . Stimulation threshold threshold for excitability , determined as the lowest stimulus current leading to consistent ventricular capture, was measured before and at least 5 min after each set of defibrillation thresholds. Ventricular Ž . effective refractory period VERP was measured at twice diastolic pacing threshold after 60 s of bipolar pacing at Ž . 300 ms drive. Programmed premature extrastimuli S2
Ž . were introduced after every eighth paced beat S1 of continuous pacing and decremented in 2 ms steps; the VERP was defined as the longest S1-S2 interval at which the S2 consistently failed to capture.
'Fastest follow frequency' was measured as the shortest Ž . cycle length of ventricular burst pacing 10 beat trains maintaining 1:1 ventricular capture.
Monophasic action potentials were measured after 2 min of ventricular pacing at 300 ms cycle length. Monophasic action potentials were displayed at 50 mmrsec and the time from the rapid upstroke to 90% repolarization from the plateau was averaged for 5 beats and recorded as the MAPD . Heart rate and mean femoral arterial blood 90 pressure were measured at the end of each of the 3 defibrillation-energy curve measurements.
At baseline, E and V were measured, followed by and 'fastest follow frequency'. The QT interval in lead II was corrected for rate using Bazett's formula:
Coherence measurement
Spatial 'coherence' between two unipolar electrograms Ž . on the same electrode 3 mm apart and between two electrodes 3 cm apart was calculated using the methods of w x Ropella et al. 19 . This parameter, termed the 'mean Ž . magnitude-squared coherence' MSC , is a measure of the relationship between two electrograms in the frequency domain, scaled from 0 to 1, with 0 indicating complete lack of coherence, or spatial relationship, and 1 indicating complete correlation between the two signals in the frequency domain. The magnitude of the squared coherence spectrum is defined as:
Ž . Ž . where x t and y t are the two simultaneous electrode recordings, and S xy is the cross power spectrum of the two signals averaged over several segments of x and y, and S xx and S yy are the individual power spectra of signals x and y averaged over the same segments. The data recorded on digital tape was stored to disk and analyzed using a customized digital acquisition package Ž and software Lab Windows, National Instruments Inc., . Austin, TX , acquired at 1200 Hz, and processed using 128 point overlapping segments.
For each animal, 3 segments of VF were selected for analysis as follows: the final 5 s of VF immediately Ž preceding defibrillation for the first, median with respect . to the total number of shocks for that condition and last episode of VF were selected. Coherence was recorded as the mean coherence value between 0-30 and 0-55 Hz and Ž the 3 values were averaged. Six episodes of VF 3 at . baseline and 3 after saline or tedisamil were therefore analyzed for each dog.
Ventricular fibrillation cycle length was measured as the average interval between visually identified deflections on the bullseye bipolar electrogram over 10 beats immediw x ately preceding defibrillation 16,23 , and the variability between these VF intervals was expressed as the coeffi-Ž . Ž . cient of variation CV s.d.rmean , expressed as % CV. The 'rate' of ventricular fibrillation was also estimated from the frequency at the largest amplitude spectral peak of the unipolar electrogram during a 5 s segment of VF, subject to Fourier analysis in the frequency range 0-55 Hz w x w x 24 and using a Hanning window 25 .
Drug administration
Ž Following the baseline measures, tedisamil Kalie . Ž . Chemie, Hanover, Germany n s 13 at a loading dose of 150 mgrkg over 10 min, followed by 5 mgrkgrmin w x Ž . maintenance infusion 26 , or saline control n s 6 was infused. Following a 15 min equilibration period, defibrillation energy requirements and electrophysiologic measures were repeated.
Statistical analysis
Changes in electrophysiological parameters, defibrillation energy and voltage requirements and coherence before and after tedisamil or saline for drug and control groups, respectively, were compared with repeated measures analysis of variance, and correlations performed using Spearman's correlation coefficient.
Results
In control animals, there was no significant change over Ž . time after saline in heart rate, arterial pressure, refractory Ž periods, rate or regularity expressed as % CV of adjacent . VF intervals of ventricular fibrillation, or coherence be-Ž . tween adjacent electrograms Table 1 .
In contrast, tedisamil caused a significant slowing in Ž heart rate from 119 " 38 to 78 " 27 beatsrmin P -. Ž 0.001 . Blood pressure remained unchanged 106 " 32 mmHg before, and 104 " 37 mmHg after tedisamil; P s . n.s. . Tedisamil prolonged monophasic action potential Ž . duration from 177 " 25 to 244 " 45 ms P -0.001 , and Table 3 Following tedisamil, the intervals between successive activations during ventricular fibrillation were significantly Ž . increased, from 121 " 24 to 190 " 63 ms P -0.001 ; VF also became more 'regular', with the coefficient of variation between successive VF intervals decreasing from 14.1 Ž . " 6.9 to 3.9 " 2.2% P -0.001 . Similarly, the spectral peak of the unipolar signal during baseline was at 8.2 " 1.9 Hz, equivalent to a cycle length of 122 " 27 ms; the peak frequency decreased to 5.5 " 1.9 Hz after tedisamil, equiv- tion. ) ) ) P -0.001; ) ) P -0.01. By two way analysis of variance, coherence was significantly Ž . increased after tedisamil P -0.001 and significantly Ž . lower with greater interelectrode distance P -0.025 , Ž . without interaction effect Fig. 1 . Fig. 2 illustrates the unipolar electrograms and the coherence spectrum for a single animal before and after tedisamil.
On visual assessment, individual electrograms developed a more regular, ordered, and organized appearance following tedisamil, with substantially greater similarity between successive local activations on any electrogram Ž . temporal stability on tedisamil than during baseline or Ž . Ž . control saline experiments Figs. 3 and 4 . In addition, Ž . DFT V , DFT J s mean defibrillation threshold in volts and joules, respectively; VFCL s ventricular fibrillation cycle length; VFCL vari-Ž . ability s % coefficient of variation CV of successive VF intervals; MSC s mean magnitude-squared coherence, scaled from 0 to 1. ) ) ) P -0.001; ) ) P -0.01. After tedisamil, 60 Hz stimulation occasionally induced a rapid, but relatively regular, monoform rhythm on the surface ECG, a pattern never seen during baseline or saline Ž . control Fig. 5 .
Ž . Defibrillation voltage requirements V decreased sig-50 nificantly following tedisamil, from 443 " 109 to 359 " 89 Ž . V P -0.001 , a mean 20 " 16% decrease. Mean E 50 Ž . decreased from 8.9 " 3.8 to 4.7 " 2.3 J P -0.001 , a 31 " 29% decrease. In control animals, there was no sig-Ž . nificant change in V or E Table 3 . 50 50
The proportional prolongation of ventricular fibrillation cycle length was inversely related to the % change in V , 50 with greatest fall in defibrillation voltage requirements in the animals with the greatest increase in ventricular fibril-Ž . lation cycle length r sy0.70, P -0.01 . The change in mean squared coherence from before to after tedisamil was Ž not significantly correlated with the change in V . Fig. 5 . Induction of a monoform but very rapid CL s150 ms organized ventricular arrhythmia during tedisamil. The first defibrillation shock is unsuccessful and a rescue shock restores sinus rhythm. This pattern was not seen at any time at baseline or in control animals. All channels labeled as in Fig. 3. 
Proarrhythmic effects
No spontaneous sustained arrhythmias were observed in any animal. In one dog, 5 min following the start of the loading infusion, spontaneous transient polymorphic ventricular tachycardia was observed, which subsided following the loading infusion and did not require intervention.
Discussion
The main finding of this study is that tedisamil, a blocker of cardiac potassium channels, increases both temporal and spatial 'organization' during ventricular fibrillation while decreasing defibrillation voltage and energy requirements.
The ability of drugs which prolong cardiac repolarization and refractory periods to decrease the voltage and energy requirements for electrical defibrillation has been consistently observed in dogs, rabbits, pigs, and man. 
Effect of tedisamil on Õentricular fibrillation
In this study, tedisamil has been shown to increase both the temporal and spatial 'organization' of adjacent ventricular electrograms during ventricular fibrillation. Ventricular fibrillation is normally characterized by both temporal and spatial heterogeneity, with a disorganized appearance of epicardial electrograms both within and between leads. Such disorganization is thought to result from a continuously changing pattern of small re-entrant wavelets or 'rotors' traversing the heart during ventricular fibrillation, with no obvious pattern. At the level of the individual cell, however, intracellular electrical potentials resemble action w x potentials recorded during normal rhythm 16 , suggesting that activation and recovery processes inside individual cells occur in a near-normal fashion. Even on a larger spatial scale, ventricular fibrillation may not be a random phenomenon. Successive sequences of apparent local activation during ventricular fibrillation have been observed to w x be 'linked' 32 , and spatially correlated at short interelecw x trode distances of 1-5 mm in the pig 33 , and can be observed to have chaotic rather than random dynamics w x 34 . Such an underlying pattern of local organization in ventricular fibrillation presumably reflects transiently repeating patterns of re-entrant ventricular activation characteristic of re-entry without anatomical block. The extent of heterogeneity recorded may thus be a function of the separation of the recording elements in space and in time, as suggested by the lower spatial coherence value at baseline between the more distant electrode pairs than for Ž . nearer neighbours Fig. 1 , Table 3 both before and after tedisamil. w x Tsuchihashi 18 previously reported that tedisamil increases cycle length of VF during ischemia and reperfusion-induced VF in isolated rat hearts. In this model, where tedisamil acts as a selective I blocker, there was a to concentration-dependent increase in VF cycle length, which was correlated with increases in QRST duration and a decreasing incidence of sustained VF. Spatial and temporal organization during re-entrant rhythms is likely to be affected by the wavelength of the arrhythmia, which has been predicted to increase with prolongation of refractory w x periods in the heart 35 . The interval between successive activations during ventricular fibrillation has been used as a measure of local refractoriness and can be modulated by w x ischemia or sympathetic stimulation 16 . Although drugs Ž . with predominantly class III action potential prolonging antiarrhythmic effects appear to have less effect at rapid stimulation rates, a phenomenon termed 'reverse use dependence', such drugs appear to prolong ventricular fibrilw x lation cycle length 36 , a state during which drug effects would be expected to be minimized due to the very rapid activation rates. Tedisamil has very potent effects on 'slowing' ventricular fibrillation, producing a 59 " 32% prolongation of VF cycle length, which is in excess of the Ž . prolongation of the effective refractory period 31 " 21% . This greater effect of refractoriness during ventricular fibrillation as opposed to ventricular pacing at a lower frequency than in VF may be considered to be a form of Ž . 'positive' frequency use dependence of antiarrhythmic drug effect.
Both the visual appearance of the electrogram pattern in individual recordings during ventricular fibrillation, as well as the regularity of successive ventricular fibrillation 'intervals' on tedisamil suggests that the successive wavelets of activation passing by a particular recording electrode are spatially oriented more similarly to each other, as well as occurring in a less variable temporal pattern. The precise definition of the spatial relationships between adjacent epicardial segments during ventricular fibrillation requires high-resolution mapping, as well as an unambiguous definition of local ventricular activation. Since the definition of local activation during ventricular fibrillation is comw x plex 9 , and without special equipment requires the arbitrary designation of a peak ydVrdt threshold or a visual w x assessment to define a local activation 9 , we sought to assess the spatial organization during ventricular fibrillation with a measurement that was not dependent on such definitions of local activation. The magnitude-squared co-Ž . w x herence MSC 19 function does not require any a priori assumptions about the nature of the electrical phenomena underlying the signals being subject to analysis. During sinus or ventricular paced rhythm, epicardial electrograms are expected to have very similar time courses, although with a phase delay. This results in relatively high coher-Ž . ence. Ventricular fibrillation in the absence of drugs , on the other hand, results in even closely adjacent signals being dissimilar in the time and frequency domains, resultw x ing in a low coherence value 19 . The magnitude of the mean squared coherence function comparing two electrograms has been proposed as a tool to separate monoform VT, expected to have high coherence, from VF, expected w x w x to have low coherence 20 . Throne et al. 21 calculated the MSC between an endocardial and an epicardial electrogram during VF in patients receiving an implantable cardioverter defibrillator; the value was 0.077 " 0.043, similar to the MSC of 'distant' electrogram pairs in our study Ž . 0.15 " 0.08 . During monoform VT, the MSC value was 0.382 " 0.189; this is higher than the value of 0.31 " 0.16 for distant electrograms in our study, suggesting that tedisamil increases coherence towards, but not achieving, values seen with scar-related, organized re-entrant VT with presumably a single re-entrant wave enveloping the entire heart during each tachycardia beat.
Using MSC as a measure of organization, tedisamil significantly increases the spatial order of unipolar electrograms located up to 3 cm apart on the epicardial left ventricular surface. This observation indicates an increased spatial organization during ventricular fibrillation following tedisamil. The higher coherence value between closely spaced electrodes versus those farther apart also suggests that the coherence function is a reasonable estimate of spatial order in VF.
The mean squared coherence variable has significant limitations, since it is subject to noise, especially at the higher frequencies near 60 Hz, and since it gives no localizing geographical information of the re-entrant waves underlying ventricular fibrillation. However, most of the information contained in this function occurs at frequencies -30 Hz, since the absolute value of the coherence function and its relative change after tedisamil are almost identical in the 0-30 versus the 0-55 Hz range. Furthermore, the Fourier transform used to characterize the signals requires stationarity and windowing. We used brief 5 s recording periods to minimize these limitations. Given the apparently periodic nature of the signals before and after tedisamil, the coherence function gives a reasonable approximation of the spatial relation between two signals.
Mechanism of the effect on defibrillation
Previous research on the mechanism of cardiac defibrillation has emphasized the events occurring immediately after the delivery of high-energy shocks to ventricular myocardium. Since high-energy shocks are known to synchronize subsequent repolarization, reducing spatial heterogeneity of repolarization immediately after the shock w x w x 7 , as well as to extend post-shock refractoriness 3,8 , it has been speculated that drugs with class III antiarrhythmic properties may facilitate defibrillation by enhancing these post-shock phenomena. As has been seen in preliminary observations following barium administration in dogs w x w x 37 , and d-and d,l-sotalol administration in man 12,36 , this study suggests that decreases in defibrillation voltage and energy requirements may occur as a result of alterations in the nature of ventricular fibrillation itself rather than, or in addition to, effects on post-shock phenomena. At least some of the effects of tedisamil on defibrillation may thus be due to an alteration in the pattern of ventricular fibrillation, increasing the homogeneity between adjacent epicardial elements.
The lack of correlation between changes in the magnitude-squared coherence and in defibrillation voltage requirements following tedisamil may be due to variability in the coherence measure between episodes of VF in the same animal. It may also be due to the coherence being an inaccurate estimate of the extent of spatial organization during VF, or may indicate that the hypothesis that organization changes result in altered defibrillation energy requirements is incorrect.
The voltage requirement for defibrillation is influenced by multiple factors, including the voltage gradient and its distribution following the electrical shock, myocardial mass, and multiple physiologic variables. These variabilities, however, are minimized in a study examining the effects of a single intervention, and the correlation between the change in 'cycle length' of ventricular fibrillation and change in defibrillation voltage requirement suggests that the prolongation of ventricular refractoriness, possibly reflecting the increase in rotor size during ventricular fibrillation, is directly related to the voltage requirement for defibrillation.
Limitations
These studies were performed on anesthetized healthy animals, and ventricular fibrillation in diseased hearts free from the complicating actions of anesthetic drugs may behave differently. As noted above, the designation of apparent local activations as true 'activations' consisting of propagated wavefronts passing by the recording electrode is arbitrary. However, the designation of local potentials as indicating activations is relatively unambiguous and has previously been used in studies of the activation rate and w x pattern during ventricular fibrillation 16, 23 . The physical distance between the unipolar electrograms subject to coherence analysis was slightly variable; the precise measure of the spatial dimensions and orientation of rotors during ventricular fibrillation awaits a more detailed and comprehensive evaluation of electrogram pattern with more accurate and subtle measurement tools. 
